Negrei Carolina, Galateanu Bianca, Stan Miriana, Balalau Cristian, Dumitru Mircea Lucian Bogdan, Ozcagli Eren, Fenga Concettina, Kovatsi Leda, Fragou Domniki, Tsatsakis Aristidis
Departament of Toxicology, Faculty of Pharmacy, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.
Department of Biochemistry and Molecular Biology, University of Bucharest, 91-95 Spl. Independenței, 050095, Bucharest, Romania.
Daru. 2017 Jun 2;25(1):14. doi: 10.1186/s40199-017-0180-2.
The discovery of a "new" psychoactive substance is a relatively exceptional event, while the regulatory response usually involved the assessment of risks to public health and inclusion of the novel substance in the national list of controlled substances. However, in recent years we have witnessed the rapid emergence of new chemical substances, which elude international control and pose a challenge to existing processes and a threat to the credibility of control systems. We currently review and present characteristics of these legal and illegal new substances and issues regarding their global monitoring and regulatory measures already taken, or in the process of being taken, for their control. The concept of prohibition applied in active substance-related legislation is rather hazard ridden as balance is required between the ban on substances of potential therapeutic use and the access on the market of high-risk substances. Current and future laws regarding psychoactive compounds.
“新型”精神活性物质的发现是相对罕见的事件,而监管应对措施通常包括评估对公众健康的风险以及将该新型物质列入国家管制物质清单。然而,近年来我们目睹了新化学物质的迅速涌现,这些物质逃避了国际管制,对现有程序构成挑战,并对管制系统的公信力构成威胁。我们目前回顾并介绍这些合法和非法新物质的特征,以及有关其全球监测和已采取或正在采取的管制措施的问题。在活性物质相关立法中应用的禁令概念存在相当大的风险,因为在禁止潜在治疗用途物质与高风险物质进入市场之间需要取得平衡。关于精神活性化合物的现行和未来法律。